logo
Sign In
  1. Home
  2. Search
FiltersReset Filters
44 results

  • actemra

    (tocilizumab)
    Medication Details
    Genentech, Inc.
    Usage: ACTEMRA (tocilizumab) is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, systemic sclerosis-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis, severe cytokine release syndrome, and COVID-19 in hospitalized adults receiving systemic corticosteroids.
    Medication Details
    Drug Interactions

  • activase

    (Alteplase)
    Medication Details
    Genentech, Inc.
    Usage: Activase is indicated for the treatment of acute ischemic stroke, acute myocardial infarction (AMI) to reduce mortality and heart failure incidence, and lysis of acute massive pulmonary embolism with significant obstruction or unstable hemodynamics. Treatment should be initiated quickly, particularly for stroke within 3 hours of symptom onset.
    Medication Details
    Drug Interactions

  • alecensa

    (ALECTINIB HYDROCHLORIDE)
    Medication Details
    Genentech, Inc.
    Usage: ALECENSA is indicated for the adjuvant treatment of adults with resected ALK-positive non-small cell lung cancer (NSCLC), and for the treatment of adult patients with metastatic ALK-positive NSCLC, both as detected by an FDA-approved test.
    Medication Details
    Drug Interactions

  • avastin

    (bevacizumab)
    Medication Details
    Genentech, Inc.
    Usage: Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.
    Medication Details
    Drug Interactions

  • cathflo activase

    (Alteplase)
    Medication Details
    Genentech, Inc.
    Usage: Cathflo® Activase® (Alteplase) is indicated for restoring function to central venous access devices by allowing the withdrawal of blood.
    Medication Details

  • cellcept

    (Mycophenolate Mofetil)
    Medication Details
    Genentech, Inc.
    Usage: CELLCEPT (mycophenolate mofetil) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used alongside other immunosuppressive agents.
    Medication Details
    Drug Interactions

  • columvi

    (Glofitamab)
    Medication Details
    Genentech, Inc.
    Usage: COLUMVI is indicated for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL, NOS) or large B-cell lymphoma from follicular lymphoma, following two or more lines of systemic therapy. This indication is granted under accelerated approval, pending further confirmation of clinical benefit.
    Medication Details
    Drug Interactions

  • cotellic

    (COBIMETINIB)
    Medication Details
    Genentech, Inc.
    Usage: COTELLIC® is indicated for adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations, in combination with vemurafenib. It is also indicated as a single agent for the treatment of adult patients with histiocytic neoplasms.
    Medication Details
    Drug Interactions

  • erivedge

    (vismodegib)
    Medication Details
    Genentech, Inc.
    Usage: ERIVEDGE is indicated for adults with metastatic basal cell carcinoma or locally advanced basal cell carcinoma that has recurred after surgery, as well as those who are not candidates for surgery or radiation.
    Medication Details
    Drug Interactions

  • esbriet

    (PIRFENIDONE)
    Medication Details
    Genentech, Inc.
    Usage: ESBRIET is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.